In the context of CF, CRISPR-based CFTR editing approaches have been explored in primary airway basal cells and induced pluripotent stem cells (iPSCs) from CF patients, as well as in CF animal models such as ferrets and pigs. This evidence concerns the gene CFTR and cystic fibrosis.